光学同调断层扫瞄(OCT)的开发平台(管线) - 开发阶段，市场区隔，地区和国家，法规途径，主要企业(2024年版)

光学相干断层扫描 (OCT) 设备可以对视网膜进行成像和测量厚度。

本报告提供光学同调断层扫瞄(OCT)市场相关调查，提供产品概要与正在开发的开发中产品趋势，各种处于开发阶段的产品的比较分析和进行中的临床试验相关资讯，参与企业的最近趋势等资讯。

目录

第1章 目录

第2章 简介

• 光学同调断层扫瞄(OCT)概要

第3章 开发中的产品

• 光学同调断层扫瞄(OCT) - 各开发阶段平台产品
• 光学同调断层扫瞄(OCT) - 各地区开发中产品
• 光学同调断层扫瞄(OCT) - 各法规途径开发中产品
• 光学同调断层扫瞄(OCT) - 估计核准日开发中产品
• 光学同调断层扫瞄(OCT) - 进行中的临床试验

第4章 光学同调断层扫瞄(OCT)- 各公司正在开发的开发中产品

• 光学同调断层扫瞄(OCT)企业- 各开发阶段平台产品
• 光学同调断层扫瞄(OCT)- 各开发阶段的开发中产品

第5章 光学同调断层扫瞄(OCT)企业和产品概要

• Brown University
• Canon USA Inc
• Columbia University
• Compact Imaging Inc.
• Costruzioni Strumenti Oftalmici Cso Srl
• Digital Diagnostics Inc
• Duke University
• George Washington University
• Heidelberg Engineering GmbH
• Kubota Vision Inc
• Leica Microsystems GmbH
• LighTopTech Corp
• Lumedica Inc
• Massachusetts General Hospital
• MicroPort Scientific Corp
• Moorfields Eye Hospital NHS Foundation Trust
• Myriad Advanced Technologies LLC
• Nippon Telegraph and Telephone Corp
• Notal Vision Inc
• Opticent Inc
• OptoQuest Inc
• Optos Plc
• OptoVibronex LLC
• Optovue Inc
• Oregon Health & Science University
• Physical Sciences Inc
• Rowiak GmbH
• Singapore Eye Research Institute
• Sinoora Inc.
• The University of Texas at Austin Division of Housing and Food Service
• Theia Imaging LLC
• TowardPi Medical Technology Ltd
• Tupai (Beijing) Medical Technology Co Ltd
• University of California Berkeley
• University of Illinois at Chicago
• University of Liverpool
• University of Louisville
• University of Pittsburgh
• University of Rochester
• Vanderbilt University

第6章 光学同调断层扫瞄(OCT)-最近的趋势

第7章 附录

GlobalData's Medical Devices sector report, "Optical Coherence Tomography (OCT) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Optical Coherence Tomography (OCT) pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Optical Coherence Tomography (OCT) equipment allows for the imaging and measurement of retinal thickness.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

• Extensive coverage of the Optical Coherence Tomography (OCT) under development
• The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
• The report reviews the major players involved in the development of Optical Coherence Tomography (OCT) and list all their pipeline projects
• The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
• The report provides key clinical trial data of ongoing trials specific to pipeline products
• Recent developments in the segment / industry

Reasons to Buy

The report enables you to -

• Formulate significant competitor information, analysis, and insights to improve R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
• Identify and understand important and diverse types of Optical Coherence Tomography (OCT) under development
• Develop market-entry and market expansion strategies
• Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
• In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1 Table of Contents

• 1.1 List of Tables
• 1.2 List of Figures

2 Introduction

• 2.1 Optical Coherence Tomography (OCT) Overview

3 Products under Development

• 3.1 Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development
• 3.2 Optical Coherence Tomography (OCT) - Pipeline Products by Territory
• 3.3 Optical Coherence Tomography (OCT) - Pipeline Products by Regulatory Path
• 3.4 Optical Coherence Tomography (OCT) - Pipeline Products by Estimated Approval Date
• 3.5 Optical Coherence Tomography (OCT) - Ongoing Clinical Trials

4 Optical Coherence Tomography (OCT) - Pipeline Products under Development by Companies

• 4.1 Optical Coherence Tomography (OCT) Companies - Pipeline Products by Stage of Development
• 4.2 Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development

5 Optical Coherence Tomography (OCT) Companies and Product Overview

• 5.1 Brown University Company Overview
  • 5.1.1 Brown University Pipeline Products & Ongoing Clinical Trials Overview
• 5.2 Canon USA Inc Company Overview
  • 5.2.1 Canon USA Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.3 Columbia University Company Overview
  • 5.3.1 Columbia University Pipeline Products & Ongoing Clinical Trials Overview
• 5.4 Compact Imaging Inc. Company Overview
  • 5.4.1 Compact Imaging Inc. Pipeline Products & Ongoing Clinical Trials Overview
• 5.5 Costruzioni Strumenti Oftalmici Cso Srl Company Overview
  • 5.5.1 Costruzioni Strumenti Oftalmici Cso Srl Pipeline Products & Ongoing Clinical Trials Overview
• 5.6 Digital Diagnostics Inc Company Overview
  • 5.6.1 Digital Diagnostics Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.7 Duke University Company Overview
  • 5.7.1 Duke University Pipeline Products & Ongoing Clinical Trials Overview
• 5.8 George Washington University Company Overview
  • 5.8.1 George Washington University Pipeline Products & Ongoing Clinical Trials Overview
• 5.9 Heidelberg Engineering GmbH Company Overview
  • 5.9.1 Heidelberg Engineering GmbH Pipeline Products & Ongoing Clinical Trials Overview
• 5.10 Kubota Vision Inc Company Overview
  • 5.10.1 Kubota Vision Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.11 Leica Microsystems GmbH Company Overview
  • 5.11.1 Leica Microsystems GmbH Pipeline Products & Ongoing Clinical Trials Overview
• 5.12 LighTopTech Corp Company Overview
  • 5.12.1 LighTopTech Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.13 Lumedica Inc Company Overview
  • 5.13.1 Lumedica Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.14 Massachusetts General Hospital Company Overview
  • 5.14.1 Massachusetts General Hospital Pipeline Products & Ongoing Clinical Trials Overview
• 5.15 MicroPort Scientific Corp Company Overview
  • 5.15.1 MicroPort Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.16 Moorfields Eye Hospital NHS Foundation Trust Company Overview
  • 5.16.1 Moorfields Eye Hospital NHS Foundation Trust Pipeline Products & Ongoing Clinical Trials Overview
• 5.17 Myriad Advanced Technologies LLC Company Overview
  • 5.17.1 Myriad Advanced Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.18 Nippon Telegraph and Telephone Corp Company Overview
  • 5.18.1 Nippon Telegraph and Telephone Corp Pipeline Products & Ongoing Clinical Trials Overview
• 5.19 Notal Vision Inc Company Overview
  • 5.19.1 Notal Vision Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.20 Opticent Inc Company Overview
  • 5.20.1 Opticent Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.21 OptoQuest Inc Company Overview
  • 5.21.1 OptoQuest Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.22 Optos Plc Company Overview
  • 5.22.1 Optos Plc Pipeline Products & Ongoing Clinical Trials Overview
• 5.23 OptoVibronex LLC Company Overview
  • 5.23.1 OptoVibronex LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.24 Optovue Inc Company Overview
  • 5.24.1 Optovue Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.25 Oregon Health & Science University Company Overview
  • 5.25.1 Oregon Health & Science University Pipeline Products & Ongoing Clinical Trials Overview
• 5.26 Physical Sciences Inc Company Overview
  • 5.26.1 Physical Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
• 5.27 Rowiak GmbH Company Overview
  • 5.27.1 Rowiak GmbH Pipeline Products & Ongoing Clinical Trials Overview
• 5.28 Singapore Eye Research Institute Company Overview
  • 5.28.1 Singapore Eye Research Institute Pipeline Products & Ongoing Clinical Trials Overview
• 5.29 Sinoora Inc. Company Overview
  • 5.29.1 Sinoora Inc. Pipeline Products & Ongoing Clinical Trials Overview
• 5.30 The University of Texas at Austin Division of Housing and Food Service Company Overview
  • 5.30.1 The University of Texas at Austin Division of Housing and Food Service Pipeline Products & Ongoing Clinical Trials Overview
• 5.31 Theia Imaging LLC Company Overview
  • 5.31.1 Theia Imaging LLC Pipeline Products & Ongoing Clinical Trials Overview
• 5.32 TowardPi Medical Technology Ltd Company Overview
  • 5.32.1 TowardPi Medical Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.33 Tupai (Beijing) Medical Technology Co Ltd Company Overview
  • 5.33.1 Tupai (Beijing) Medical Technology Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
• 5.34 University of California Berkeley Company Overview
  • 5.34.1 University of California Berkeley Pipeline Products & Ongoing Clinical Trials Overview
• 5.35 University of Illinois at Chicago Company Overview
  • 5.35.1 University of Illinois at Chicago Pipeline Products & Ongoing Clinical Trials Overview
• 5.36 University of Liverpool Company Overview
  • 5.36.1 University of Liverpool Pipeline Products & Ongoing Clinical Trials Overview
• 5.37 University of Louisville Company Overview
  • 5.37.1 University of Louisville Pipeline Products & Ongoing Clinical Trials Overview
• 5.38 University of Pittsburgh Company Overview
  • 5.38.1 University of Pittsburgh Pipeline Products & Ongoing Clinical Trials Overview
• 5.39 University of Rochester Company Overview
  • 5.39.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview
• 5.40 Vanderbilt University Company Overview
  • 5.40.1 Vanderbilt University Pipeline Products & Ongoing Clinical Trials Overview

6 Optical Coherence Tomography (OCT)- Recent Developments

• 6.1 Apr 23, 2024: Topcon Receives Additional FDA 510(k) Clearance for 3D Optical Coherence Tomography (Maestro2)
• 6.2 Nov 15, 2023: Topcon Medical Systems Receives 510(K) Clearance For Maestro2
• 6.3 Nov 05, 2023: Heidelberg Engineering Receives Additional 510(K) Clearance for Spectralis HRA+OCT

7 Appendix

• 7.1 Methodology
• 7.2 About GlobalData
• 7.3 Contact Us
• 7.4 Disclaimer

List of Tables

• Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development
• Optical Coherence Tomography (OCT) - Pipeline Products by Territory
• Optical Coherence Tomography (OCT) - Pipeline Products by Regulatory Path
• Optical Coherence Tomography (OCT) - Pipeline Products by Estimated Approval Date
• Optical Coherence Tomography (OCT) - Ongoing Clinical Trials
• Optical Coherence Tomography (OCT) Companies - Pipeline Products by Stage of Development
• Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development
• Glossary

List of Figures

• Optical Coherence Tomography (OCT) - Pipeline Products by Stage of Development
• Optical Coherence Tomography (OCT) - Pipeline Products by Territory
• Optical Coherence Tomography (OCT) - Pipeline Products by Regulatory Path
• Optical Coherence Tomography (OCT) - Pipeline Products by Estimated Approval Date
• Optical Coherence Tomography (OCT) - Ongoing Clinical Trials